Why Eli Lilly Stock Just Popped

Eli Lilly (NYSE: LLY) banal bounced backmost 2.4% by 9:50 a.m. ET Monday aft taking a tumble past week.

Shares of the large pharma banal and shaper of Mounjaro and Zepbound GLP-1 value nonaccomplishment drugs sank respective percent Thursday aft Hims & Hers Health (NYSE: HIMS) announced it would merchantability an Ozempic lookalike pill to vie with Novo Nordisk's (NYSE: NVO) Wegovy pill -- and with Eli Lilly's Mounjaro and Zepbound injectable value nonaccomplishment drugs arsenic well.

Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »

Over the weekend, everything changed.

First, connected Friday, the U.S. Food and Drug Administration announced plans to ace down connected Hims & Hers, perchance cutting disconnected entree to ingredients the institution needs to manufacture Ozempic copycats oregon seizing Hims & Hers products. Hims said Saturday it volition not merchantability its pill aft all.

This morning, Novo Nordisk sued Hims & Hers anyway, demanding a imperishable injunction against the institution for selling compounded copies of its drugs successful immoderate signifier (injectable or pill-based).

Hims rapidly responded with a jingoistic accusation that "Danish company" Novo was trying to deprive "millions of Americans [of] compounded medications for entree to personalized care." It's worthy pointing out, though, that Hims & Hers's connection to merchantability knockoff Ozempic pills for $49 a period poses arsenic large a menace to American Eli Lilly arsenic it does to Novo.

More importantly for investors, Eli Lilly could payment adjacent much from Novo Nordisk's suit (and the FDA investigation, and Hims' capitulation) than volition Novo. After all, astatine past report, Lilly was charging $299 a period for Zepbound (which requires a needle), versus Novo charging $149 for Wegovy successful pill form.

Hims & Hers' $49 terms tag was a bigger menace to Lilly. Its disappearance is adjacent amended quality for Lilly than for Novo.

Before you bargain banal successful Eli Lilly, see this:

The Motley Fool Stock Advisor expert squad conscionable identified what they judge are the 10 champion stocks for investors to bargain now… and Eli Lilly wasn’t 1 of them. The 10 stocks that made the chopped could nutrient monster returns successful the coming years.

Consider erstwhile Netflix made this database connected December 17, 2004... if you invested $1,000 astatine the clip of our recommendation, you’d person $443,299!* Or erstwhile Nvidia made this database connected April 15, 2005... if you invested $1,000 astatine the clip of our recommendation, you’d person $1,136,601!*